PL1633325T3 - Emulsja do poporodowej substytucji hormonalnej - Google Patents

Emulsja do poporodowej substytucji hormonalnej

Info

Publication number
PL1633325T3
PL1633325T3 PL04741802T PL04741802T PL1633325T3 PL 1633325 T3 PL1633325 T3 PL 1633325T3 PL 04741802 T PL04741802 T PL 04741802T PL 04741802 T PL04741802 T PL 04741802T PL 1633325 T3 PL1633325 T3 PL 1633325T3
Authority
PL
Poland
Prior art keywords
oil emulsion
phase
gestagen
estrogen
hormone substitution
Prior art date
Application number
PL04741802T
Other languages
English (en)
Inventor
Sonja Brömer
Jörg Nehne
Frank Pohlandt
Original Assignee
Braun Melsungen Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Braun Melsungen Ag filed Critical Braun Melsungen Ag
Publication of PL1633325T3 publication Critical patent/PL1633325T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Dispersion Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
PL04741802T 2003-06-18 2004-06-15 Emulsja do poporodowej substytucji hormonalnej PL1633325T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03013790A EP1488785A1 (de) 2003-06-18 2003-06-18 Ölemulsion zur postnatalen Hormonsubstitution
PCT/EP2004/051114 WO2004110402A1 (de) 2003-06-18 2004-06-15 Ölemulsion zur postnatalen hormonsubstitution
EP04741802A EP1633325B1 (de) 2003-06-18 2004-06-15 Emulsion zur postnatalen hormonsubstitution

Publications (1)

Publication Number Publication Date
PL1633325T3 true PL1633325T3 (pl) 2007-08-31

Family

ID=33395816

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04741802T PL1633325T3 (pl) 2003-06-18 2004-06-15 Emulsja do poporodowej substytucji hormonalnej

Country Status (14)

Country Link
US (1) US20070071777A1 (pl)
EP (2) EP1488785A1 (pl)
JP (1) JP2006527736A (pl)
CN (1) CN1809339B (pl)
AT (1) ATE359061T1 (pl)
BR (1) BRPI0410558A (pl)
CA (1) CA2526567A1 (pl)
DE (1) DE502004003483D1 (pl)
ES (1) ES2281813T3 (pl)
MX (1) MXPA05012411A (pl)
PL (1) PL1633325T3 (pl)
PT (1) PT1633325E (pl)
RU (1) RU2318494C2 (pl)
WO (1) WO2004110402A1 (pl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2155205B1 (en) * 2007-06-21 2011-12-21 Pantarhei Bioscience B.V. Treatment of meconium aspiration syndrome with estrogens
JP5753784B2 (ja) * 2008-10-10 2015-07-22 ダラ・バイオサイエンシズ，インコーポレイテッド スピカマイシン誘導体を用いて疼痛を治療又は予防する方法
US9034389B2 (en) 2009-03-11 2015-05-19 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US8993625B2 (en) 2009-03-11 2015-03-31 Stable Solutions Llc Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
US20110200645A1 (en) * 2010-02-18 2011-08-18 Martek Biosciences Corporation DHA Free Fatty Acid Emulsions
US20110206741A1 (en) * 2010-02-18 2011-08-25 Martek Biosciences Corporation DHA Triglyceride Emulsions
US20110200644A1 (en) * 2010-02-18 2011-08-18 Martek Biosciences Corporation DHA Ester Emulsions
EP2544707B1 (en) * 2010-03-09 2018-11-21 Dignity Health Methods for inhibiting preterm labor and uterine contractility disorders and preventing cervical ripening
TW201138782A (en) 2010-04-26 2011-11-16 Besins Healthcare Lu Sarl Low-oil pharmaceutical emulsion compositions comprising progestogen
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US8633178B2 (en) 2011-11-23 2014-01-21 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
TWI651098B (zh) * 2012-02-29 2019-02-21 Ｂ 柏藍麥桑根公司 含荷爾蒙的乳劑
BR112014021390A2 (pt) * 2012-02-29 2019-09-24 Braun Melsungen Ag emulsão do tipo óleo em água contendo hormônio e composição farmacêutica
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
EP3145489A1 (en) 2014-05-22 2017-03-29 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
KR102424837B1 (ko) 2014-09-19 2022-07-25 헤론 테라퓨틱스 인코포레이티드 아프레피탄트의 에멀젼 제형
US9974742B2 (en) 2016-02-01 2018-05-22 Heron Therapeutics, Inc. Emulsion formulations of an NK-1 receptor antagonist and uses thereof
US10285998B1 (en) 2018-04-04 2019-05-14 The Menopause Method, Inc. Composition and method to aid in hormone replacement therapy
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60258110A (ja) * 1984-06-05 1985-12-20 Daigo Eiyou Kagaku Kk 静脈注射可能なプロゲステロン乳化注射液
AU614465B2 (en) * 1989-04-05 1991-08-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
CN1029293C (zh) * 1993-01-01 1995-07-12 浙江省中医院 薏苡仁中性油脂乳剂
SE9301171D0 (sv) * 1993-04-07 1993-04-07 Ab Astra Pharmaceutical composition containing lipophilic drugs
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
CN1204238C (zh) * 2000-10-18 2005-06-01 李大鹏 从核桃仁中提取的核桃仁油组合物及其药物制剂

Also Published As

Publication number Publication date
JP2006527736A (ja) 2006-12-07
CN1809339A (zh) 2006-07-26
US20070071777A1 (en) 2007-03-29
WO2004110402A1 (de) 2004-12-23
PT1633325E (pt) 2007-05-31
ES2281813T3 (es) 2007-10-01
DE502004003483D1 (de) 2007-05-24
CA2526567A1 (en) 2004-12-23
EP1633325A1 (de) 2006-03-15
BRPI0410558A (pt) 2006-06-20
MXPA05012411A (es) 2006-02-13
EP1633325B1 (de) 2007-04-11
ATE359061T1 (de) 2007-05-15
AU2004246823A1 (en) 2004-12-23
CN1809339B (zh) 2010-06-23
EP1488785A1 (de) 2004-12-22
RU2318494C2 (ru) 2008-03-10
RU2006101322A (ru) 2006-06-10

Similar Documents

Publication Publication Date Title
PL1633325T3 (pl) Emulsja do poporodowej substytucji hormonalnej
Kinyamu et al. Modifying chromatin to permit steroid hormone receptor-dependent transcription
Eng et al. Attention-deficit/hyperactivity disorder and the menstrual cycle: Theory and evidence
Schantz et al. Cognitive effects of endocrine-disrupting chemicals in animals
Fensome et al. New progesterone receptor antagonists: 3, 3-disubstituted-5-aryloxindoles
AU2001287918A1 (en) Preparation of vitamin emulsions and concentrates thereof
KR20050002602A (ko) 자동 구성 시스템 및 방법
JP2006527736A5 (pl)
EP2433951A3 (en) A process for the preparation of drospirenone
Roy et al. An atom counting strategy towards analyzing the biological activity of sex hormones
AU1967300A (en) Estrogenic estra-1,3,5(10)-trienes with differential effects on the alpha and beta estrogen receptors, having a linear hydrocarbon chain of from 5-9 carbon atoms in position 11
CA2138515A1 (en) Controller for Computer Program Running Multiple Threads Enabling Selective Graphic User Interface (GUI) Control and Command Line (TTY) Control from Terminal Emulator or User Program
Gardner et al. Selective blockade of estrogen-induced uterine responses by the antiestrogen nafoxidine
CN104133675A (zh) 一种基于动态配置技术的配网多主题应用界面集成方法
TW200722075A (en) Propofol-containing fat emulsion
SG11201806346WA (en) Remediation and/or restoration of an anoxic body of water
Cepa et al. Molecular mechanisms of aromatase inhibition by new A, D-ring modified steroids.
SG11201807074VA (en) Novel pyrrolidine derivatives
BR0311184A (pt) Terapia de reposição de hormÈnio
MXPA02012436A (es) Metodos para disociar la actividad no genotropica de la genotropica de los receptores esteroideos.
CN107943477A (zh) 一种iOS上通过XML实现UI布局的方法
Kang et al. Synthesis and identification of novel oxa-steroids as progesterone receptor antagonists
WO2001024826A3 (en) Inrease of enos activity through activation of the pi3-kinase/akt pathway by estrogens
NO20052286L (no) Fremgangsmate for utvinning av en naturlig blanding av konjugerte hesteostrogener med et sterkt redusert innhold av ikke-konjugerte, lipofile forbindelser
TW200505940A (en) Method for obtaining a natural mixture of conjugated equine estrogens